| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
| [2] |
Dos Anjos Pultz B, da Luz FA, de Faria PR, et al. Far beyond the usual biomarkers in breast cancer: a review [J]. J Cancer, 2014,5(7):559-571.
|
| [3] |
Kwan JY, Psarianos P, Bruce JP, et al. The complexity of microRNAs in human cancer [EB/OL]. [2016-02-20].http:/ /jrr.oxfordjournals.org/content/early/2016/03/15/jrr.rrw009.long.
|
| [4] |
Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease [J]. Cell Mol Life Sci,2016,73(13):2491-2509.
|
| [5] |
Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J]. Nature,2010,464(7291):1071-1076.
|
| [6] |
Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60 770 full-length cDNAs [J]. Nature,2002,420(6915):563-573.
|
| [7] |
Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs [J]. Cell,2009,136(4):629-641.
|
| [8] |
Yang C,Wu D,Gao L,et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives [ J].Oncotarget,2016,7(12):13 479-13 490.
|
| [9] |
Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer [J]. Oncogene,2009,28(2):195-208.
|
| [10] |
Han L, Ma P, Liu SM, et al. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects [J]. Tumour Biol,2016,37(5):6847-6854.
|
| [11] |
Yan R, Cao J, Song C, et al. Polymorphisms in lncRNA HOTAIR and susceptibility to breast cancer in a Chinese population [J]. Cancer Epidemiol,2015,39(6):978-985.
|
| [12] |
Barsyte-Lovejoy D, Lau SK, Boutros PC, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis [J]. Cancer Res,2006,66(10):5330-5337.
|
| [13] |
Raveh E, Matouk IJ, Gilon M, et al. The H19 long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory [J]. Mol Cancer,2015,14(1):184.
|
| [14] |
Shore AN, Herschkowitz JI, Rosen JM. Noncoding RNAs involved in mammary gland development and tumorigenesis:there's a long way to go[J]. J Mammary Gland Biol Neoplasia,2012,17(1):43-58.
|
| [15] |
Li C, Lei B, Huang S, et al. H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma [J]. Am J Transl Res,2015,7(10):1747-1764.
|
| [16] |
Silva JM,Boczek NJ,Berres MW,et al. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation [J]. RNA Biol,2011,8(3):496-505.
|
| [17] |
Hassan S, Buchanan M, Jahan K, et al. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model [J]. Int J Cancer,2011,129(1):225-232.
|
| [18] |
Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer [J]. Oncogene,2003,22(39):8031-8041.
|
| [19] |
Feng T, Shao F, Wu Q, et al. miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation [J]. Oncotarget,2016,7(13):16 205-16 216.
|
| [20] |
Zhao Z, Chen C, Liu Y, et al. 17beta-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level [J]. Biochem Biophys Res Commun, 2014, 445(2):388-393.
|
| [21] |
Chou J, Wang B, Zheng T, et al. MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42 [J]. Biochem Biophys Res Commun, 2016, 472(1):262-269.
|
| [22] |
Loewer S, Cabili MN, Guttman M, et al. Large intergenic non-coding RNA-ROR modulates reprogramming of human induced pluripotent stem cells [J]. Nat Genet,2010,42(12):1113-1117.
|
| [23] |
Hou P, Zhao Y, Li Z, et al. LincRNA-ROR induces epithelial-tomesenchymal transition and contributes to breast cancer tumorigenesis and metastasis [J]. Cell Death Dis,2014,5: e1287.
|
| [24] |
Novikova IV,Hennelly SP,Sanbonmatsu KY. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator [J].Nucleic Acids Res,2012,40(11):5034-5051.
|
| [25] |
Yan R, Wang K, Peng R, et al. Genetic variants in lncRNA SRA and risk of breast cancer [J]. Oncotarget,2016,7(16):22 486-22 496.
|
| [26] |
Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma [J]. Clin Cancer Res,2006,12(16):4851-4858.
|
| [27] |
Huang J, Zhou N, Watabe K, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) [J]. Cell Death Dis,2014,5: e1008.
|
| [28] |
Chen S, Shao C, Xu M, et al. Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1 [J]. Int J Clin Exp Pathol,2015,8(8):9052-9061.
|
| [29] |
Froberg JE, Yang L, Lee JT. Guided by RNAs: X-inactivation as a model for lncRNA function [J]. J Mol Biol, 2013, 425 (19):3698-3706.
|
| [30] |
Weakley SM, Wang H, Yao Q, et al. Expression and function of a large non-coding RNA gene XIST in human cancer [J]. World J Surg,2011,35(8):1751-1756.
|
| [31] |
Richardson AL, Wang ZC, De Nicolo A, et al. X chromosomal abnormalities in basal-like human breast cancer [J]. Cancer Cell,2006,9(2):121-132.
|
| [32] |
Vincent-Salomon A, Ganem-Elbaz C, Manié E, et al. X inactivespecific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors [J]. Cancer Res,2007,67(11):5134-5140.
|
| [33] |
Askarian-Amiri ME, Crawford J, French JD, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer [J]. RNA,2011,17(5):878-891.
|
| [34] |
Jiang M, Huang O,Xie Z,et al. A novel long non-coding RNA-ARA:adriamycin resistance-associated [J]. Biochem Pharmacol, 2014,87(2):254-283.
|
| [35] |
Iacoangeli A, Lin Y, Morley EJ, et al. BC200 RNA in invasive and preinvasive breast cancer [J]. Carcinogenesis, 2004, 25 (11):2125-2133.
|
| [36] |
De Leeneer K, Claes K. Non coding RNA molecules as potential biomarkers in breast cancer [J]. Adv Exp Med Biol, 2015, 867:263-275.
|
| [37] |
Redis RS, Sieuwerts AM, Look MP, et al. CCAT2, a novel long noncoding RNA in breast cancer: expression study and clinical correlations[J]. Oncotarget,2013,4(10):1748-1762.
|
| [38] |
Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway [J]. Onco Targets Ther,2015,8:2657-2664.
|
| [39] |
Pickard MR, Williams GT. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy [J].Breast Cancer Res Treat,2014,145(2):359-370.
|
| [40] |
Matouk IJ, Raveh E, Abu-lail R, et al. Oncofetal H19 RNA promotes tumor metastasis [J]. Biochim Biophys Acta, 2014, 1843 (7):1414-1426.
|
| [41] |
Wan G, Hu X, Liu Y, et al. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation [J]. EMBO J,2013,32(21):2833-2847.
|
| [42] |
Shi Y, Lu J, Zhou J, et al. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells [J].Biochem Biophys Res Commun,2014,446(2):448-453.
|
| [43] |
Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB [J]. PLoS Genet,2013,9(3):e1003368.
|
| [44] |
Sotillo E, Thomas-Tikhonenko A. The long reach of noncoding RNAs[J]. Nat Genet,2011,43(7):616-617.
|
| [45] |
Hung T, Wang Y, Lin MF, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters [J]. Nat Genet,2011,43(7):621-629.
|
| [46] |
Gumireddy K, Li A, Yan J, et al. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step [J]. EMBO J,2013,32(20):2672-2684.
|
| [47] |
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A,2003,100(7):3983-3988.
|
| [48] |
张春影, 卢颖, 李青, 等. 上皮间质转化及其相关信号通路与乳腺癌干细胞的关系[J/CD]. 中华乳腺病杂志(电子版),2015,9 (1):54-57.
|
| [49] |
Tordonato C,Di Fiore PP,Nicassio F. The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors [J]. Front Genet,2015,6:72.
|
| [50] |
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells [J]. Cell,2008,133(4):704-715.
|
| [51] |
Pádua Alves C, Fonseca AS, Muys BR, et al. Brief report: The lincRNA HOTAIR is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines [J]. Stem Cells,2013,31(12):2827-2832.
|
| [52] |
Xue X, Yang YA, Zhang A, et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [J].Oncogene,2016,35(21):2746-2755.
|
| [53] |
Shi SJ, Wang LJ, Yu B, et al. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer [J].Oncotarget,2015,6(13):11 652-11 663.
|
| [54] |
Chen M, Zhuang C, Liu Y, et al. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer [J]. Cancer Lett, 2016,376(1):155-164.
|
| [55] |
Rioth MJ, Thota R, Staggs DB, et al. Pragmatic precision oncology:The secondary uses of clinical tumor molecular profiling [J]. J Am Med Inform Assoc,2016,23(4):773-776.
|